These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18285822)

  • 1. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
    Francisco G; Menezes PR; Eluf-Neto J; Chammas R
    Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
    Qiu L; Wang Z; Shi X; Wang Z
    Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.
    Han S; Zhang HT; Wang Z; Xie Y; Tang R; Mao Y; Li Y
    Eur J Hum Genet; 2006 Oct; 14(10):1136-44. PubMed ID: 16791138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
    Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2537-41. PubMed ID: 17164382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.
    Wang S; Wang F; Shi X; Dai J; Peng Y; Guo X; Wang X; Shen H; Hu Z
    Eur J Cancer; 2009 Nov; 45(16):2874-81. PubMed ID: 19467856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
    Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
    Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
    Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.
    Li Y; Gu S; Wu Q; Li Y; Fu X; Mao Y; Huang Y; Xie Y
    Eur J Hum Genet; 2007 Sep; 15(9):967-73. PubMed ID: 17522621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
    Fontana L; Bosviel R; Delort L; Guy L; Chalabi N; Kwiatkowski F; Satih S; Rabiau N; Boiteux JP; Chamoux A; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(3B):1853-6. PubMed ID: 18630471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.
    Vineis P; Manuguerra M; Kavvoura FK; Guarrera S; Allione A; Rosa F; Di Gregorio A; Polidoro S; Saletta F; Ioannidis JP; Matullo G
    J Natl Cancer Inst; 2009 Jan; 101(1):24-36. PubMed ID: 19116388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
    Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
    Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.